| Document |
Document Title |
|
WO/2024/097355A1 |
Described herein are bifunctional compounds, as well as pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, or tautomers thereof, that function to recruit certain deubiquitinases to a target protein for modula...
|
|
WO/2024/086933A1 |
Disclosed are novel fused mescaline derivative compounds, notably C1 -substituted isopropylamine fused heterocyclic mescaline derivatives, including C1-substituted isopropylamine fused dioxolane and fused dioxane mescaline derivatives (F...
|
|
WO/2024/086218A1 |
In one aspect, the present disclosure provides a method of synthesis for methylone HCl, with 3,4-methylenedioxypropiophenone (MDP) as the starting material. In another aspect, the present disclosure provides stereoisomers of methylone. I...
|
|
WO/2024/082333A1 |
Provided is the use of a catalyst in the catalysis of a reaction of an epoxy compound and carbon dioxide. The catalyst comprises a spirocyclic compound, and the spirocyclic compound comprises at least one of compounds as shown in the str...
|
|
WO/2024/080128A1 |
The present invention addresses the problem of providing an actinic ray-sensitive or radiation-sensitive resin composition from which a resist pattern having a small LWR can be formed. An actinic ray-sensitive or radiation-sensitive resi...
|
|
WO/2024/065042A1 |
Provided are novel sulfur-containing lipids and nanoparticles containing such lipids and a cargo molecule, such as a nucleic acid, methods to formulate said lipids with nucleic acids to produce lipid nanoparticles and chemical routes for...
|
|
WO/2024/065043A1 |
Provided are lipids and nanoparticles containing such lipids and a cargo molecule, such as nucleic acid, methods to formulate said lipids with nucleic acids to produce lipid nanoparticles and chemical routes for making the lipids. The li...
|
|
WO/2024/067560A1 |
Disclosed in the present invention are a sulfonamide compound and the medical use thereof as a STING inhibitor, specifically, a compound as represented by formula (I) or a pharmaceutically acceptable salt or ester or solvate thereof, whi...
|
|
WO/2024/070968A1 |
Provided are: an actinic ray-sensitive or radiation-sensitive resin composition containing (A) a resin the polarity of which is increased due to acid activity, (B) a compound which produces an acid when irradiated with actinic rays or ra...
|
|
WO/2024/065041A1 |
The present disclosure relates to a sulfur-containing ionizable lipid or a pharmaceutically acceptable salt thereof that incorporates a dithioacetal or dithioketal moiety in one or more of its lipophilic chains. Further provided is a del...
|
|
WO/2024/057751A1 |
Provided are: a radioactive-ray-sensitive resin composition that can exhibit sufficient levels of sensitivity and CDU performance when a next-generation technology is applied to the composition; and a pattern formation method. The radioa...
|
|
WO/2024/051975A1 |
The present invention relates to a compound of formula (I) as defined herein. The present invention further relates to a mixture comprising or consisting of a compound of formula (la) and a compound of formula (lb) as defined herein, whe...
|
|
WO/2024/047227A1 |
The present invention relates to compounds of Formula (I) and (II) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical c...
|
|
WO/2024/040906A1 |
Disclosed is a method for recycling a lithium-ion battery electrolyte. By means of freezing a used lithium-ion battery and then dissembling same, environmental pollution caused by volatilization and decomposition of the electrolyte can b...
|
|
WO/2024/039599A1 |
The subject matter disclosed generally relates to phenethylamines or cathinones covalently bound to a chemical moiety in a prodrug form. The presently described technology allows slow/sustained/controlled delivery of the parent phenethyl...
|
|
WO/2024/026568A1 |
Disclosed are novel fused heterocyclic mescaline derivative compounds, notably fused heterocyclic mescaline derivatives and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compound...
|
|
WO/2024/011067A2 |
A method of manufacturing R-MDMA by forming a Grignard reagent from 5-bromobenzodioxole, treating the Grignard reagent with S-propylene oxide to form chirally pure alcohol (1), activating the alcohol as mesylate (2), converting to chiral...
|
|
WO/2024/001487A1 |
The present invention relates to the technical field of green, clean and efficient catalysis, and in particular, to a method for synthesizing a cyclic carbonate from carbon dioxide and an epoxy compound by means of a catalytic reaction a...
|
|
WO/2024/001497A1 |
The present invention relates to the technical field of catalysis, in particular to a catalyst for synthesizing a cyclic carbonate and a synthetic method for a cyclic carbonate. The present invention provides a novel catalyst having a hy...
|
|
WO/2023/247725A1 |
A process for preparing solketal acrylate by transesterifying ethyl acrylate with solketal, comprising the steps of: (i) reacting ethyl acrylate with solketal in the presence of a catalyst comprising titanium(IV) or zirconium(IV) and a s...
|
|
WO/2023/250247A2 |
A composition of a crystalline form salt or polymorph of R-MDMA. A pharmaceutical composition of a crystalline form salt or polymorph of R-MDMA and pharmaceutically acceptable excipients. A method of treating an individual for a medical ...
|
|
WO/2023/248723A1 |
Provided is an immobilized zinc complex comprising at least: a compound represented by general formula (1) (where R1 and R2 each represent a monovalent hydrocarbon group, R3 represents a divalent hydrocarbon group, R4 to R7 each represen...
|
|
WO/2023/243671A1 |
Provided is a method for producing alkylene carbonate by using a first reaction vessel containing a catalyst-containing reaction liquid and gaseous carbon dioxide, the method comprising: a step (A) for supplying an alkylene oxide-contain...
|
|
WO/2023/241223A1 |
Provided are a catalyst for synthesizing polyimide and a preparation method therefor, and a polyimide compound. The structural formula of the catalyst is represented by formula (1): in formula (1), R3 is selected from O or NH; R4 is sele...
|
|
WO/2023/238718A1 |
Provided are: a difluorobutene acid amide compound having an excellent controlling effect against harmful weeds; and an herbicidal composition thereof. The herbicidal composition contains a difluorobutene acid amide compound represented ...
|
|
WO/2023/228490A1 |
Provided are: a catalyst for organic synthesis use, which has a high catalytic activity, can be easily separated by solid/liquid separation from a reaction system, and enables highly efficient synthesis of an organic compound; and a meth...
|
|
WO/2023/229295A1 |
The present invention relates to a phenylpropene derivative, and a pharmaceutical composition for the prevention or treatment of cancer, comprising the phenylpropene derivative as an active ingredient. The phenylpropene derivative disclo...
|
|
WO/2023/202652A9 |
Provided herein is a pharmaceutical combination comprising a Glutamine antagonist, or a pharmaceutically acceptable salt thereof, a stereoisomer thereof, a tautomer thereof, and an isotopic substitution thereof, and an additional therape...
|
|
WO/2023/227676A1 |
The present invention relates to the use of malonic acid monoamides and malonamide esters of the formula (I) wherein the variables are as defined in the claims and the description, for controlling unwanted vegetation, to a method for com...
|
|
WO/2023/221320A1 |
The present invention relates to the field of pharmaceutical excipients, and particularly, to an improved low-toxicity and highly efficient pharmaceutical excipient of an orthoester mixture, a method for preparing same, and a local susta...
|
|
WO/2023/215989A1 |
Provided herein are novel sulfur-containing lipids having a structure of Formula A or a salt thereof. The compounds may be formulated in a lipid nanoparticle for use in the delivery of charged cargo such as nucleic acids for use in the t...
|
|
WO/2023/217119A1 |
Disclosed herein is a diclofenac prodrug represented by formula (I), wherein each of the substituents is given the definition as set forth in the Specification and Claims. Also disclosed is a method for alleviating arthritis, which inclu...
|
|
WO/2023/219703A1 |
Provided herein are perfluoro copolymers of a perfluoro dioxole monomer, a perfluoro dioxane monomer, and an optional perhalo monomer. Methoda of making the perfluoro copolymers and methods of using the perfluoro copolymers are also disc...
|
|
WO/2023/214706A1 |
The present invention relates to a novel diaryl-propanedione derivative compound, a preparation method therefor, and a pharmaceutical composition comprising same for prevention or treatment of inflammatory or allergic diseases. More spec...
|
|
WO/2023/202559A1 |
The application provides a phenyl acrylic compound, and a preparation method and application thereof. The phenyl acrylic compound has a structure as shown in formula (I). The phenyl acrylic compound provided by the present application ca...
|
|
WO/2023/201999A1 |
The present invention provides a production method and system for an electrolyte additive. Vinylene carbonate is prepared by means of three steps of chlorination reaction, dechlorination reaction, and purification, and the ratio of chlor...
|
|
WO/2023/200244A1 |
The present invention relates to a monomer composition for synthesizing recycled plastics, a method for manufacturing same, and recycled plastics and molded articles using same, wherein the monomer composition comprises an aromatic diol ...
|
|
WO/2023/200245A1 |
The present invention relates to a monomer composition for synthesizing a recycled plastic, a manufacturing method therefor, and a recycled plastic and a molded product which use same, wherein the monomer composition includes an aromatic...
|
|
WO/2023/200247A1 |
The present invention relates to: a monomer composition for synthesizing a recycled plastic, a preparation method therefor, and a recycled plastic and a molded product which use same, wherein the monomer composition includes an aromatic ...
|
|
WO/2023/193341A1 |
Provided are a sphingolipid compound shown in formula (I), a liposome containing the sphingolipid compound, and an application. The sphingolipid compound is prepared by taking a long-chain alkyl group as a hydrophobic tail part, and bond...
|
|
WO/2023/191952A1 |
The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, ro...
|
|
WO/2023/180162A1 |
The present invention relates to a new method for producing compounds of formula (II) by reacting compounds of formula (I) with hydrogen peroxide in the presence of a solvent, in the presence of a catalyst, in the presence of a buffer an...
|
|
WO/2023/179071A1 |
A method for preparing a high-purity fluorination derivative of ethylene carbonate. The method comprising: using chloroethylene carbonate or 4,5-dichloroethylene carbonate as a raw material and a fluoride as a fluorinating agent, subject...
|
|
WO/2023/182378A1 |
The present invention provides: a polycarbonate resin that includes a structural unit represented by formula (1) (in which A is an optionally substituted trivalent alicyclic moiety, and B is an optionally substituted monovalent alicyclic...
|
|
WO/2023/182309A1 |
This compound is represented by formula (1). (In formula (1), R1 represents a hydrogen atom, a methyl group, an ethyl group, a methacryloyloxymethyl group, or an acryloyloxymethyl group. R2 represents a hydrogen atom or a methyl group. R...
|
|
WO/2023/182772A1 |
The present invention relates to a synthesis method for alkylene carbonate, for example, alkylene carbonate comprising propylene carbonate, ethylene carbonate, and the like and, more specifically to, a synthesis method for alkylene carbo...
|
|
WO/2023/182771A1 |
The present invention relates to a method for synthesizing alkylene carbonate, that is, alkylene carbonate including ethylene carbonate and propylene carbonate, and, more specifically, to a method for electrochemically synthesizing alkyl...
|
|
WO/2023/177590A1 |
A method for direct synthesis of cyclic carbonates is achieved by reacting at least one epoxide with carbon dioxide in the presence of a choline catalyst, such as choline chloride, under mild conditions such as a temperature between abou...
|
|
WO/2023/177877A1 |
Described herein are ralinepag prodrugs, as well as pharmaceutical compositions thereof, and methods of use thereof in the treatment of diseases or conditions that would benefit from treatment with a prostacyclin (IP) receptor agonist co...
|
|
WO/2023/166004A1 |
The present invention relates to the field of organic synthesis and more specifically it concerns a process for preparing compound of formula (I). The compound of formula (III), the compound of formula (IV) and the compound of formula (V...
|
